Introduction to Regulatory Education For Industry Redi Annual Conference 2023 Day 2 Session 3
Exploring Regulatory Education For Industry Redi Annual Conference 2023 Day 2 Session 3 reveals several interesting facts. FDA discusses: * The new PMR commitments under PDUFA VII; * How CDER is working to advance rare disease cures with the ...
Regulatory Education For Industry Redi Annual Conference 2023 Day 2 Session 3 Comprehensive Overview
FDA experts: *Review the new BsUFA FDA discusses considerations and best practices throughout a human drug recall life cycle including when to conduct a recall, ... The FDA will present: *How to leverage SBIA's Resources; *An overview of the CDER STAR Pilot Program and discuss ...
Content in this video provided updates and cutting-edge insight on novel artificial intelligence (AI), clinical trial designs and ...
Summary & Highlights for Regulatory Education For Industry Redi Annual Conference 2023 Day 2 Session 3
- Suranjan De, Deputy Director of
- Learn directly from the FDA's
- The FDA discusses *How clinical trials are advancing through the use of DHTs, DCTs and point of care trials along with providing ...
- The biologics track will focus on the developmental and
- The devices track will provide an overview and highlights of how to get a new medical device to market. It will also discuss some ...
Stay tuned for more updates related to Regulatory Education For Industry Redi Annual Conference 2023 Day 2 Session 3.